Harvard Medical School (HMS) is the medical school of Harvard University and is located in the Longwood Medical Area in Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools in the United States, and provides patient care, medical education, and research training through its 15 clinical affiliates and research institutes, including Massachusetts General Hospital (MGH), Boston Children's Hospital, Dana–Farber Cancer Institute, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Mount Auburn Hospital, McLean Hospital, Cambridge Health Alliance, The Baker Center for Children and Families, Spaulding Rehabilitation Hospital, and others
Massachusetts General Hospital is a teaching hospital located in the West End neighborhood of Boston, Massachusetts. It is the original and largest clinical education and research facility of Harvard Medical School/Harvard University, and houses the world's largest hospital-based research program with an annual research budget of more than $1.2 billion in 2021. It is the third-oldest general hospital in the United States with a patient capacity of 999 beds. Along with Brigham and Women's Hospital, Mass General is a founding member of Mass General Brigham, formerly known as Partners HealthCare, the largest healthcare provider in Massachusetts.
Moses Judah Folkman was an American biologist and pediatric surgeon best known for his research on tumor angiogenesis, the process by which a tumor attracts blood vessels to nourish itself and sustain its existence. He founded the field of angiogenesis research, which has led to the discovery of a number of therapies based on inhibiting or stimulating neovascularization.
National Institutes of Health Director's Pioneer Award is a research initiative first announced in 2004 designed to support individual scientists' biomedical research. The focus is specifically on "pioneering" research that is highly innovative and has a potential to produce paradigm shifting results. The awards, made annually from the National Institutes of Health common fund, are each worth $500,000 per year, or $2,500,000 for five years.
Soma Weiss was a Hungarian-born American physician.
Charles Alderson Janeway, Jr. was an American immunologist who helped create the modern field of innate immunity. A member of the National Academy of Sciences, he held a faculty position at Yale University's Medical School and was an Howard Hughes Medical Institute Investigator.
Donald E. Ingber is an American cell biologist and bioengineer. He is the founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, the Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. He is also a member of the American Institute for Medical and Biological Engineering, the National Academy of Engineering, the National Academy of Medicine, the National Academy of Inventors, and the American Academy of Arts and Sciences.
The American Society for Investigative Pathology (ASIP) is a society of biomedical scientists who investigate mechanisms of disease. ASIP membership includes scientists in the academic, government, hospital, and pharmaceutical arenas that focus their research on the pathogenesis, classification, diagnosis and manifestations of disease. Research findings are ultimately used in the understanding, diagnosis and treatment of human diseases. The word pathology is derived from the Greek word "pathos" meaning "disease."
Robert Edward Gross was an American surgeon and a medical researcher. He performed early work in pediatric heart surgery at Boston Children's Hospital. Gross was president of the American Association for Thoracic Surgery, a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences.
Atul Janardhan Butte or Atul J. Butte is an American biomedical informatician, pediatrician, and biotechnology entrepreneur. He is currently the Priscilla Chan and Mark Zuckerberg Distinguished Professor at the University of California, San Francisco. Since April 2015, Butte has serves as inaugural director of UCSF's Bakar Computational Health Sciences Institute.
Elazer R. Edelman is an American engineer, scientist and cardiologist. He is the Edward J. Poitras Professor in Medical Engineering and Science at the Massachusetts Institute of Technology (MIT), Professor of Medicine at Harvard Medical School and at Brigham and Women's Hospital (BWH), and a practicing cardiologist at BWH. He is the director of the MIT Center for Clinical and Translational Research (CCTR), the Harvard-MIT Biomedical Engineering Center, and was previously director of the Institute for Medical Engineering and Science (IMES) at MIT. He is also the Program Director of the MIT Graduate Education in Medical Sciences program within the Harvard-MIT Division of Health Sciences and Technology.
Jochen Reiser is a physician-scientist and a healthcare leader. He is the President of the University of Texas Medical Branch (UTMB) and CEO of the UTMB Health System, which includes the oldest medical school and nursing school in Texas. As chief executive officer, he oversees the enterprise which includes multiple campuses, five health science colleges, the Galveston National Laboratory (BSL-4) and the Correctional Health Care Services for most of Texas.
The Louis and Artur Lucian Award in Cardiovascular Diseases is a prize for cardiovascular medicine conferred by McGill University. Described as Canada's "top cardiovascular research prize", it has been awarded annually since 1978, except in 2007.
Lucila Ohno-Machado is a biomedical engineer and Deputy Dean for Biomedical Informatics at the Yale University School of Medicine. She is an elected member of the American Society for Clinical Investigation and the National Academy of Medicine.
Patricia Kilroy Donahoe is an American pediatric surgeon and a leading researcher in the field of developmental biology and oncology. She was the president of the American Pediatric Surgical Association from 2006 to 2007. She currently serves as the director of pediatric surgical research laboratories and chief emerita of pediatric surgical services at Massachusetts General Hospital.
Roy S. Herbst is an American oncologist who is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.
Jon Christopher Aster is an American pathologist who researches the role of the notch signaling pathway in leukemia. He is the Michael Gimbrone Professor of Pathology at Harvard Medical School. He has been a co-editor of the Annual Review of Pathology: Mechanisms of Disease since 2016.
Mel B. Feany is an American neuropathologist and geneticist at Brigham and Women's Hospital who researches neurodegenerative disease. She is a co-editor of the Annual Review of Pathology: Mechanisms of Disease.
Michael Joseph Mina is an American epidemiologist, immunologist and physician. He was formerly an assistant professor of Epidemiology & Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, assistant Professor of Pathology at Brigham and Women's Hospital, Harvard Medical School, and currently Chief Medical Officer at eMed. and Chief Medical and Science Officer at Oncodea.
Christiana Ruhrberg is a German-British cell biologist who is Professor of Neuronal and Vascular Biology. University College London She investigates how cells interact during the development of mammals and examines how similar interactions influence the repair and regeneration of adult organs.
